Famotidine: New York hospitals studying heartburn drug as Covid-19 treatment
CNNCNN — Hospitals in New York are giving Covid-19 patients heartburn medicine to see if it helps fight the virus, according to the doctor who initiated the trial. Preliminary results of the clinical trial of famotidine, the active ingredient in Pepcid, could come out in the next few weeks, said Dr. Kevin Tracey, president of Feinstein Institutes for Medical Research at Northwell Health, which runs 23 hospitals in the New York City area. Learning from Chinese patients’ medications Tracey and his colleagues got the idea to study famotidine after it was observed that some patients in China taking the drug fared better than patients not taking the drug. When Callahan and the Chinese doctors looked closer, they found that many of the people with lower incomes were taking famotidine, whereas the wealthier patients tended to take a different, more expensive drug. Tracey said in addition to the observation in Chinese patients, Florida-based Alchem Laboratories used a computer model to make a list of existing drugs that might fight coronavirus, and famotidine showed up near the top of the list.
History of this topic
(Explained) Trump’s Covid-19 treatments: Remdesivir, dexamethasone, antibody therapy, and more
CNN
Famotidine: Common heartburn drug may have helped 10 patients at home with mild coronavirus
CNN
Anthony Fauci: Science shows hydroxychloroquine is not effective as a coronavirus treatment
CNN
Hydroxychloroquine linked to deaths, heart risks in COVID-19 study
LA Times
Famotidine study shows Covid-19 patients who took heartburn drug were less likely to die, but researchers caution more research is needed
CNN
Heartburn medicine Pepcid studied as potential coronavirus treatment
The Independent
New York hospitals testing heartburn drug Pepcid for COVID-19 treatment
India TV NewsDiscover Related
